This trial is testing a device called Ekso to see if it is safe and effective for people with spinal cord injuries or similar neurological weaknesses. The device helps the person stand, walk, and turn, and sit down. The trial will test if the person using Ekso can safely balance and walk without losing balance, and if they improve in weight shift and other activities.
2 Primary · 3 Secondary · Reporting Duration: Testing Day 1 - 3 and follow up testing Week 6 and Week 12.
40 Total Participants · 1 Treatment Group
Primary Treatment: Ekso exoskeleton · No Placebo Group · N/A
Age 18 - 65 · All Participants · 7 Total Inclusion CriteriaMark “Yes” if the following statements are true for you: